Tafenoquine inhibits replication of SARS-Cov-2 at pharmacologically relevant concentrations in vitro

Updated: Jul 16, 2020

60 Degrees Pharmaceuticals Announces Positive Results of Cell Culture Testing of

ARAKODA (tafenoquine) for COVID-19

Find full press release in attachment below

Tafenoquine Press Release July 2020

.pdf

Download PDF • 202KB

Please find the link and attached document of the published article and findings below

Dow et al 2020 TQ COVID 19 20200708

.pdf

Download PDF • 324KB